CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-10 | Kim Jong Joseph Chief Executive Officer | Grant or award · Restricted Stock Unit | +317,100 | 317,100 | ||
| 2017-03-10 | KIES PETER CFO | Grant or award · Common Stock Options | +100,000 | $6.68 | $668K | 100,000 |
| 2017-03-10 | KIES PETER CFO | Grant or award · Restricted Stock Unit | +61,300 | 61,300 | ||
| 2017-03-10 | Weiner David B. Director | Grant or award · Common Stock Option | +60,000 | $6.68 | $401K | 60,000 |
| 2017-03-10 | Weiner David B. Director | Grant or award · Restricted Stock Unit | +35,000 | 35,000 | ||
| 2017-03-09 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion | +25,000 | 88,513 | ||
| 2017-03-09 | Sardesai Niranjan Chief Operating Officer | Shares withheld for taxes | −7,648 | $6.61 | $51K | 80,865 |
| 2017-03-09 | Sardesai Niranjan Chief Operating Officer | Exercise or conversion · Restricted Stock Unit | −25,000 | 50,000 | ||
| 2017-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +25,000 | 50,758 | ||
| 2017-03-09 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −7,648 | $6.61 | $51K | 43,110 |
| 2017-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −25,000 | 50,000 | ||
| 2017-03-09 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +57,334 | 2,021,944 | ||
| 2017-03-09 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −17,787 | $6.61 | $118K | 2,004,157 |
| 2017-03-09 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −57,334 | 114,666 | ||
| 2017-03-09 | KIES PETER CFO | Exercise or conversion | +25,000 | 56,219 | ||
| 2017-03-09 | KIES PETER CFO | Shares withheld for taxes | −9,171 | $6.61 | $61K | 47,048 |
| 2017-03-09 | KIES PETER CFO | Exercise or conversion · Restricted Stock Unit | −25,000 | 50,000 | ||
| 2017-03-09 | Weiner David B. Director | Exercise or conversion | +5,334 | 728,956 | ||
| 2017-03-09 | Weiner David B. Director | Exercise or conversion | +10,000 | 738,956 | ||
| 2017-03-09 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −5,334 | 10,666 |
Page 46 of 49 · 961 trades